Design, organocatalytic synthesis, and bioactivity evaluation of enantiopure fluorinated LpxC inhibitors
Enantiopure compounds with a strategically incorporated fluorine atom intended to enhance LpxC inhibition have been synthesized using an organocascade fluorination reaction as the key step. These are the first low molecular weight LpxC inhibitors to contain a fluorine atom on a critically important...
Saved in:
Published in | Organic & biomolecular chemistry Vol. 18; no. 3; pp. 5867 - 5878 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
CAMBRIDGE
Royal Soc Chemistry
05.08.2020
Royal Society of Chemistry |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Enantiopure compounds with a strategically incorporated fluorine atom intended to enhance LpxC inhibition have been synthesized using an organocascade fluorination reaction as the key step. These are the first low molecular weight LpxC inhibitors to contain a fluorine atom on a critically important chiral center that is substituted with two pharmacophoric moieties, and were thusly designed to provide new SAR data for this class of compounds. Fluorinated compounds were evaluated against ESKAPE pathogens and exhibited MICs of ≤12.5 μg mL
−1
against
Pseudomonas aeruginosa
.
Enantiopure compounds designed to enhance LpxC inhibition
via
strategic incorporation of a fluorine atom were synthesized using an organocascade fluorination reaction as the key step. |
---|---|
Bibliography: | H Electronic supplementary information (ESI) available: Additional experimental details and compound characterization, table of bacteria strains used in this study. Copies of 1 13 10.1039/d0ob01125h C, and HPLC spectra. See DOI ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1477-0520 1477-0539 1477-0539 |
DOI: | 10.1039/d0ob01125h |